Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pigs ‘could be a better model for human influenza’
The results suggest that targeting the lower respiratory tract with aerosol vaccination could be more effective in preventing severe disease.

’Striking difference’ to the same vaccine in pigs and ferrets 

A new study has raised questions about whether ferrets are a good model for studying human influenza.

Ferrets are considered to be a gold standard animal model for influenza research, but scientists now say that S-FLU - a universal flu vaccine candidate - evokes different immune responses in pigs and ferrets.

Findings published in the Journal of Immunology suggest that pigs may offer a more faithful representation of influenza disease in humans.

S-FLU is a weakened strain of flu virus, designed to trigger a response from T cells that are able to react to multiple strains of flu.

Researchers found a ‘striking difference’ in the way that pigs and ferrets responded to the same vaccine. When administered to pigs, the vaccine activated a newly-identified type of T cell, against a flu virus of a different strain. Disease severity was reduced, but the amount of virus stayed the same.

When it was administered to ferrets, however, the viral replication was reduced, as was the amount of virus transmitted to other animals. Scientists said pigs provide a model that is closer in size and has a very similar respiratory system to humans. Pigs are also naturally infected with influenza viruses.

The team’s discovery of a new type of T cell - tissue-resident memory T-cells - also sheds light on how influenza is fought in the lung.

The results also suggest that targeting the lower respiratory tract with aerosol vaccination could be more effective in preventing severe disease in pigs. This finding offers promising evidence that the same could be true in humans.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.